FDA Technology Transfer
FDA's Technology Transfer Program provides help and guidance to the FDA community for its technology transfer and intellectual property concerns. It assists with the transfer of FDA technologies to outside organizations so that the technologies might be fully developed for introduction into the commercial marketplace. It also facilitates the exchange of research resources between FDA scientists and external scientific research groups.
To enable collaborations and scientific exchanges, the Technology Transfer Program uses a variety of agreement mechanisms, including Cooperative Research and Development Agreements (CRADAs), Material Transfer Agreements (MTAs), and Confidential Disclosure Agreements (CDAs).
It also assists FDA inventors with the reporting of new technologies, which are then considered for patent application filing. Patenting and licensing of FDA technologies is carried out when these activities support FDA’s public health mission.
More information on FDA's Technology Transfer can be found here.
Specific questions regarding FDA inventions and technologies, research collaborations, CRADAs, or other technology transfer matters, may be directed to:
Alice Y. Welch, Ph.D., Technology Development Officer, FDA, 301-796-8449, Alice.Welch@fda.hhs.gov